| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jeffrey W. Albers | Director | $22.8M | -$6.88M | -23.2% | Mar 12, 2025 |
| Kate Haviland | Chief Executive Officer | $17.5M | -$1.82M | -9.43% | Mar 5, 2025 |
| Alexis Borisy | Director | $7.87M | Jun 12, 2024 | ||
| Fouad Namouni | President, R & D | $7.68M | -$901K | -10.5% | Mar 5, 2025 |
| Christina Rossi | Chief Operating Officer | $7.53M | -$1.69M | -18.4% | Mar 24, 2025 |
| Michael Landsittel | Chief Financial Officer | $7.27M | -$2.35M | -24.4% | Mar 5, 2025 |
| Tracey L. McCain | Evp And Chief Legal Officer | $6.71M | -$467K | -6.51% | Mar 5, 2025 |
| Nicholas Lydon | Director | $6.17M | Jun 12, 2024 | ||
| Percy H. Carter | Chief Scientific Officer | $5.84M | -$993K | -14.5% | Mar 5, 2025 |
| Philina Lee | Chief Commercial Officer | $5.83M | -$4.24M | -42.1% | Mar 5, 2025 |
| Debra Durso-Bumpus | Chief People Officer | $5.2M | -$9.62M | -64.9% | Mar 5, 2025 |
| Christopher K. Murray | Chief Technical Operations | $3.45M | Mar 7, 2024 | ||
| L. Becker Hewes | Chief Medical Officer | $2.97M | -$5.28M | -64% | Mar 5, 2025 |
| Ariel Hurley | Principal Accounting Officer | $2.17M | -$1.63M | -42.8% | Mar 5, 2025 |
| Mark Alan Goldberg | Director | $1.99M | Jun 12, 2024 | ||
| Lynn Seely | Director | $1.46M | Jun 12, 2024 | ||
| Daniella Beckman | Director | $1.21M | Jun 12, 2024 | ||
| Habib J. Dable | Director | $988K | Jun 12, 2024 | ||
| John Tsai | Director | $988K | Jun 12, 2024 | ||
| George Demetri | Director | $837K | Jun 21, 2022 | ||
| Charles A. Rowland Jr | Director | $591K | Jun 2, 2021 | ||
| Tango Therapeutics, Inc. | Director | $411K | Dec 8, 2021 | ||
| Lonnel Coats | Director | $261K | -$1.87M | -87.8% | Nov 20, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|